课题基金 / 基金详情

THE EFFECTS OF LOW POWER LASER ON PAIN PROJECTION MECHANISMS

THE EFFECTS OF LOW POWER LASER ON PAIN PROJECTION MECHANISMS
低功率激光对疼痛投射机制的影响
批准号:
05807141
负责人:
SHIMOYAMA Naohito
金额:
$0.9万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994

项目摘要

项目成果

SHIMOYAMA Naohito的其他基金

相似基金

相关文献

中文摘要
翻译
本课题由3项研究组成,旨在阐明其镇痛作用的机制。1)对人红细胞低渗溶血的影响; 2)对钠、钾通道的影响; 3)对DPPc膜(人工膜)的影响。[结果1]激光能稳定受损红细胞膜,激活红细胞的变形能力。[结果2]激光照射后,钾离子浓度增加,钠离子浓度无明显变化。[结果3]激光辐照对相变温度也没有影响。[结论]低功率He-Ne激光照射对DPPC人工膜的物理性能无影响。但对人红细胞的低渗溶血有抑制作用。这表明激光对红细胞膜具有保护作用,使其免于低渗溶血,并使膜稳定。
英文摘要
This project was constructed of 3 studies for clarifing the mechanism of analgesic effect. 1) the effect on hypotonic hemolysis of human red blood cell, 2) the effects on sodium and potasium channel, 3) the effects on DPPc membrane (artificial membrane),[result 1] The laser stabilized the membrane of damaged red blood cells and the deformability was activated by the laser irradiation.[result 2] We observed the potasium ions increseed, but the sodium ions were no changed by the laser irradiation.[result 3] Phase transition temperature was also unchanged by the laser irradiation.[conclusion] These results suggest that low-power He-Ne laser irradiation do not affect the physical characteristics fo artificial DPPC membranes. But the hypotonic hemolysis in human red cells were inhibited by the laser irradiation. This suggest that the laser has protective effects on red cell membranes from hypotonic hemolysis and stabilize the membranes.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
飯島一彦,下山直人,他: "疼痛外来における低出力レーザー療法" 骨・関節・靱帯. 7(6). 669-675 (1994)
Kazuhiko Iijima、Naoto Shimoyama 等人:“门诊疼痛诊所的低功率激光治疗”《骨骼、关节和韧带》7(6) (1994)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
下山直人: "低出力レーザー" エキスパートナース. 10(12). 92-97 (1994)
Naoto Shimoyama:“低功率激光”专家护士 10(12) 92-97 (1994)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
10
    Astudy on Opioid-Reducing Effect of NMDA Receptor Antagonists as Analgesics
    海外基金